Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Final auction amounts of mortgage covered bonds series 11F, 12E and 12F
-
Kforce Inc. Announces Transfer of Listing of Common Stock to the New York Stock Exchange
-
Spectral Medical Provides April Tigris Trial Update
-
Metasphere Labs Announces a Follow-Up Event Regarding Bitcoin’s Defi Revolution
-
Tyson Foods Reports Second Quarter 2024 Results
-
Plus Therapeutics Announces Private Placement Financing of up to $18 Million
-
Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences
-
ETFS Capital Files Definitive Proxy Statement and Releases Letter to Fellow WisdomTree Stockholders
-
Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders
-
Dime Announces Expansion in Williamsburg With Deposit-Focused Group
-
Quipt Home Medical Corp. to Announce Fiscal Second Quarter 2024 Financial Results on May 15, 2024
-
ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants
-
Allot Announces the Appointment of Eyal Harari as Chief Executive Officer
-
Flow Capital Announces Repayment of USD 4.5 Million Investment
-
SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors
-
N2OFF: Save Foods to Target California’s Hemp Market
-
Skyward Specialty Announces Secondary Offering of Its Common Stock
-
Flash News: OKX Launches Cryptopedia Season 17 Campaign Featuring 6,666,666 Ultiverse Token Prize Pool
-
Stellantis Pro One Achieves No. 1 Spot in Middle East & Africa Region and Strengthens Commercial Vehicle Leadership in Europe and South America
-
Stellantis Pro One Achieves No. 1 Spot in Middle East & Africa Region and Strengthens Commercial Vehicle Leadership in Europe and South America
-
Mikra Announces Joint Product with Jose Bautista
-
KP Tissue Announces Filing and Mailing of the Management Proxy Materials in Connection with its 2024 Annual Meeting of Shareholders
-
BiomX to Present at the 2024 RBC Capital Markets Global Healthcare Conference
-
AMG Reports Financial and Operating Results for the First Quarter of 2024
-
Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
-
Osisko Metals Announces Updated Mineral Resource Estimate at Gaspé Copper – Indicated Resource of 495 Mt Grading 0.37% Copper Equivalent
-
LSL Pharma Group Enters Into Binding Agreement to Acquire Quebec Competitor
-
Join Mobilicom’s Exclusive Live Investor Webinar and Q&A Session on May 9
-
BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update
-
The Simply Good Foods Company to Participate in the Goldman Sachs Global Staples Forum
-
EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA Trial of DURAVYU™ in Non-Proliferative Diabetic Retinopathy
-
GXO to Manage Logistics Operations for Levi Strauss & Co at State-of-the-Art German Distribution Center
-
Inari Medical to Participate in the 2024 Bank of America Securities Healthcare Conference
-
Voyager Therapeutics Announces First Quarter 2024 Conference Call and Webcast
-
LOBO EV Reports Fiscal Year 2023 Results and Sets Stage for Accelerating Growth in 2024
-
Join Mobilicom’s Exclusive Live Investor Webinar and Q&A Session on May 9
-
Brookfield Asset Management and Castlelake to Enter into Strategic Partnership
-
Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
-
Foghorn Therapeutics Provides First Quarter 2024 Financial and Corporate Update
-
GXO to Manage Logistics Operations for Levi Strauss & Co at State-of-the-Art German Distribution Center
-
CW Petroleum Corp (CWPE) Submits Application to List on OTCQB
-
Agios to Present at the BofA Securities 2024 Health Care Conference on May 16, 2024
-
Apellis Pharmaceuticals to Host a Fireside Chat at the Bank of America Securities Healthcare Conference
-
Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024
-
Signify share repurchase periodic update
-
Verkkokauppa.com Oyj: Jesper Blomster appointed as new CFO and member of the management team in Verkkokauppa.com Oyj
-
Boussard & Gavaudan Investment Management LLP: Form 8.3 -
-
Lerøy Seafood Group ASA: Notice of General Shareholders' Meeting
-
Neumora Therapeutics to Participate in Upcoming Conferences in May
-
Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Spring Meeting (SAWC Spring)


